LH monthly performance report
View LH's monthly returns, drawdown, and seasonality trends — updated every month.
LH monthly report
—
Key takeaways
- LabCorp (LH) closed September 2026 at $324.51, down 2.45% for the month and +18.40% over the trailing 12 months.
- Year-to-date, LH is +29.35%, outperforming the S&P 500 which has returned +10.58% YTD.
- The stock is trading +17.17% versus its 200-day moving average ($276.95), a bullish technical signal.
- Over the past three years, LH has underperformed the S&P 500 by −9.15%, with a relative strength index reading of 94.9.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
LabCorp ended September 2026 at $324.51, posting a monthly return of −2.45%. The S&P 500 returned −1.69% over the same window, leaving relative performance at −0.76%.
The current quarter stands at +15.90% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +17.17% versus the 200-day moving average ($276.95).
Year-to-date, LH is +29.35% against SPY +10.58%, a gap of +18.77%. The stock is currently −5.06% below its 52-week high, with maximum 3-year drawdown at −17.36%.
| Period | LH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.17% | −0.44% | +0.61% |
| 1 Week | +1.06% | −1.10% | +2.16% |
| 1 Month | −2.45% | −1.69% | −0.76% |
| 3 Months | +21.92% | −0.10% | +22.03% |
| 6 Months | +20.00% | +13.21% | +6.79% |
| YTD | +29.35% | +10.58% | +18.77% |
| 12 Months | +18.40% | +14.25% | +4.15% |
| 3 Years | +60.93% | +70.07% | −9.15% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +10.43% |
| #2 | Jan 2025 | +8.93% |
| #3 | Nov 2023 | +8.60% |
| #4 | Jan 2026 | +8.23% |
| #5 | Jun 2026 | +7.67% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2025 | −11.53% |
| #2 | Apr 2024 | −7.82% |
| #3 | Mar 2026 | −7.72% |
| #4 | Mar 2025 | −7.29% |
| #5 | Dec 2025 | −6.66% |
| Quarter | Return |
|---|---|
| Q2 2025 | +12.79% |
| Q3 2025 | +9.35% |
| Q4 2025 | −12.60% |
| Q1 2026 | +6.35% |
| Q2 2026 | +4.94% |
| Q3 2026 (QTD) | +15.90% |
| Year | Return |
|---|---|
| 2023 | +12.35% |
| 2024 | +0.89% |
| 2025 | +9.40% |
| 2026 | +29.35% |
| Metric | Value |
|---|---|
| 52-Week High | $341.80 (2026-08-27) |
| 52-Week Low | $244.52 (2025-11-07) |
| Current Price | $324.51 |
| 200-Day Moving Average | $276.95 |
| Price vs 200DMA | +17.17% |
| 3-Year Maximum Drawdown | −17.36% (2025-04-21) |
| Current Drawdown from 52W High | −5.06% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 94.9 |
| 3-Year Excess Return vs S&P 500 | −9.15% |
| RS Peak | 110.1 (Oct 2023) |
| RS Trough | 74.7 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was LH's return for this report period?
LH returned −2.45% in the latest monthly window ending 2026-09-16.
Has LH outperformed SPY year to date?
YTD LH: +29.35% vs SPY: +10.58%.
What is LH's 12-month return?
+18.40% over the trailing 12 months.
Is LH above or below its 200-day moving average?
Price is +17.17% versus 200DMA ($276.95).
What is the maximum drawdown in the 3-year window?
−17.36% on 2025-04-21.